These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11583301)

  • 1. Revival of plasmin as a therapeutic agent?
    Collen D
    Thromb Haemost; 2001 Sep; 86(3):731-2. PubMed ID: 11583301
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of alpha-adrenoceptor antagonist dihydroergotoxin in experimental anticoagulant and fibrinolytic therapy.
    Kalishevskaya TM; Golubeva MG; Bashkov GV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):157-61. PubMed ID: 2459012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis of the abdominal aorta in a newborn: case report and review of literature.
    de Godoy JM; De Marchi CH; Silva MG; Carvalho MC; Moscardini A; Medeiros JC
    J Pediatr Surg; 2003 Apr; 38(4):E11. PubMed ID: 12677598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The action of modified plasmin on the lysis of experimental thrombi].
    Kizim AI; Pokrovskaia TN
    Vrach Delo; 1990 May; (5):39-40. PubMed ID: 1697714
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of thromboembolism of the aortic bifurcation with fibrinolysin and heparin].
    Mel'nik PA; Gudz SG
    Vrach Delo; 1966 Oct; 10():144-5. PubMed ID: 4231520
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure and activity of plasmin and other direct thrombolytic agents.
    Novokhatny V
    Thromb Res; 2008; 122 Suppl 3():S3-8. PubMed ID: 18718639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
    Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
    J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Healing of a patient with thromboembolism of the bifurcation of the aorta with a mixture of fibrinolysin and heparin].
    Fesenko IP
    Klin Med (Mosk); 1973 Jan; 51(1):131-2. PubMed ID: 4271811
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 12. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous aortic thrombosis in a neonate.
    Suri M; Ramji S; Thirupuram S; Sharma BK
    Indian Pediatr; 1994 Jul; 31(7):846-9. PubMed ID: 7890351
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
    Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
    Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.
    Comerota AJ
    Thromb Res; 2008; 122 Suppl 3():S20-6. PubMed ID: 18701142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human microplasmin: production and potential therapeutic properties.
    Nagai N; Demarsin E; Van Hoef B; Wouters S; Cingolani D; Laroche Y; Collen D
    J Thromb Haemost; 2003 Feb; 1(2):307-13. PubMed ID: 12871505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lysis of arterial thrombi in rabbits and dogs by use of activated human plasminogen (fibrinolysin) (plasmin).
    GROSSI CE; CLIFFTON EE
    Surgery; 1955 May; 37(5):794-802. PubMed ID: 14373295
    [No Abstract]   [Full Text] [Related]  

  • 19. Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization.
    Nagai N; De Mol M; Van Hoef B; Verstreken M; Collen D
    Blood; 2001 May; 97(10):3086-92. PubMed ID: 11342434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptokinase in chronic arterial occlusive disease.
    Martin M; Schoop W; Zeitler E
    JAMA; 1970 Feb; 211(7):1169-73. PubMed ID: 5466969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.